Enteric Coated Rabeprazole Sodium and Domperidone Sustained Release Capsule

Description

Enteric-coated Rabeprazole Sodium and Domperidone Sustained Release Capsule is a medication that combines two active ingredients: rabeprazole sodium and domperidone. Let’s break down what each of these components does:

Rabeprazole Sodium:

Rabeprazole is a proton pump inhibitor (PPI) that reduces the production of stomach acid. Help in   for the treatment of conditions such as gastroesophageal reflux disease (GERD), ulcers in the stomach or duodenum, and conditions where excessive stomach acid production is a problem. Rabeprazole works by inhibiting the proton pumps in the stomach lining, which are responsible for the secretion of acid into the stomach. By reducing acid production, it can help alleviate symptoms like heartburn, acid regurgitation, and stomach pain.

Domperidone:

Domperidone is a medication that acts as a dopamine receptor antagonist. It has prokinetic effects, meaning it enhances the movements or contractions of the stomach and intestines. Domperidone  treats conditions like nausea and vomiting, as well as disorders of the gastrointestinal motility.

It works by blocking dopamine receptors in the brain and gut, leading to increased gut motility and decreased nausea and vomiting.

• Enteric-coated:

• Enteric coating is a special outer layer applied to a medication. That allows it to pass through the stomach without being broken down by stomach acid. This is particularly useful for drugs that can destroy or become less effective in the acidic environment of the stomach.

• Sustained release:

• Sustained-release capsules  release the medication slowly over an extended period of time. This can help maintain a consistent level of the medication in the bloodstream, potentially reducing the frequency of dosing and providing more stable therapeutic effects.

The combination of rabeprazole sodium and domperidone in an enteric-coated sustained-release capsule suggests that this medication formulates to address conditions involving excessive stomach acid production, acid-related disorders, and gastrointestinal motility issues, while also ensuring a controlled and extended release of the active ingredients